ASXC News and Press, Asensus Surgical Inc Com From 01/23/23

Asensus Surgical ( NYSE: ASXC ) said it received CE Mark for an expansion of machine vision capabilities on its cleared device Intelligent Surgical Unit (ISU). The company noted that with this CE Marking, the expanded ISU capabilities are now commercially available in key geographies,...

RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced receipt of CE Mar...

Summary Intuitive Surgical, Inc. is no doubt a nearly perfect company, although the investment is currently worrisome. With continued headwinds and a lofty valuation, a lot rides on what Intuitive Surgical will do with their $4 billion in cash. This article will summarize recent Int...

Asensus Surgical ( NYSE: ASXC ) shares dipped 8% premarket on Monday after the medical device company provided 2022 year-end corporate update , guiding for revenue of ~$6.8M - $7.4M. Analysts expect the firm to generate annual revenue of $7.6M . Approximately 2,650 procedu...

RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2022...

Summary Intuitive Surgical has enjoyed years of strong growth but there is still more room for further expansion for all major revenue streams. Ion Endoluminal is expected to remain a relatively small revenue stream. Competition is increasing which may pressurize margins and market ...

RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the manageme...

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kitakyushu G...

RESEARCH TRIANGLE PARK, N.C., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kashiwa Kose...

RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that GPR Gesundhe...